Medical Care
Global DNA Medicine Based on DNA Modification Market Research Report 2025
- Mar 11, 25
- ID: 74194
- Pages: 81
- Figures: 89
- Views: 21
The global market for DNA Medicine Based on DNA Modification was valued at US$ 13690 million in the year 2024 and is projected to reach a revised size of US$ 48640 million by 2031, growing at a CAGR of 20.2% during the forecast period.
Advanced Therapy Based on Gene is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient"s cells instead of using drugs or surgery.
The advanced therapy based on gene market is driven by the potential to revolutionize healthcare by offering personalized and targeted treatments for genetic disorders and other diseases. Advanced therapy based on gene includes gene therapy, cell therapy, and gene editing techniques, which aim to modify or replace faulty genes to treat or cure diseases at the genetic level. The rise in the understanding of genetic mechanisms and advancements in biotechnology and genetic engineering contribute to market growth as these therapies hold promise for previously untreatable conditions. Moreover, increasing investment in research and clinical trials and the support from regulatory agencies for accelerated approval further boost the development and commercialization of advanced gene therapies. However, the market also faces challenges, including the complexity of manufacturing and delivering gene-based therapies, safety concerns related to viral vectors and off-target effects in gene editing, and high treatment costs. Additionally, addressing regulatory requirements and ensuring accessibility and affordability of advanced gene therapies can pose obstacles for broader adoption. To succeed, companies must focus on research and development to advance the safety and efficacy of gene-based therapies, collaborate with healthcare stakeholders to build robust infrastructure, and address the challenges to fully realize the transformative potential of advanced therapy based on gene in modern medicine.
This report aims to provide a comprehensive presentation of the global market for DNA Medicine Based on DNA Modification, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DNA Medicine Based on DNA Modification.
The DNA Medicine Based on DNA Modification market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global DNA Medicine Based on DNA Modification market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the DNA Medicine Based on DNA Modification companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Segment by Type
Viral
Non-viral
Segment by Application
Neurological Diseases
Cancer
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of DNA Medicine Based on DNA Modification company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Advanced Therapy Based on Gene is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient"s cells instead of using drugs or surgery.
The advanced therapy based on gene market is driven by the potential to revolutionize healthcare by offering personalized and targeted treatments for genetic disorders and other diseases. Advanced therapy based on gene includes gene therapy, cell therapy, and gene editing techniques, which aim to modify or replace faulty genes to treat or cure diseases at the genetic level. The rise in the understanding of genetic mechanisms and advancements in biotechnology and genetic engineering contribute to market growth as these therapies hold promise for previously untreatable conditions. Moreover, increasing investment in research and clinical trials and the support from regulatory agencies for accelerated approval further boost the development and commercialization of advanced gene therapies. However, the market also faces challenges, including the complexity of manufacturing and delivering gene-based therapies, safety concerns related to viral vectors and off-target effects in gene editing, and high treatment costs. Additionally, addressing regulatory requirements and ensuring accessibility and affordability of advanced gene therapies can pose obstacles for broader adoption. To succeed, companies must focus on research and development to advance the safety and efficacy of gene-based therapies, collaborate with healthcare stakeholders to build robust infrastructure, and address the challenges to fully realize the transformative potential of advanced therapy based on gene in modern medicine.
This report aims to provide a comprehensive presentation of the global market for DNA Medicine Based on DNA Modification, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DNA Medicine Based on DNA Modification.
The DNA Medicine Based on DNA Modification market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global DNA Medicine Based on DNA Modification market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the DNA Medicine Based on DNA Modification companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Segment by Type
Viral
Non-viral
Segment by Application
Neurological Diseases
Cancer
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of DNA Medicine Based on DNA Modification company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global DNA Medicine Based on DNA Modification Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Viral
1.2.3 Non-viral
1.3 Market by Application
1.3.1 Global DNA Medicine Based on DNA Modification Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global DNA Medicine Based on DNA Modification Market Perspective (2020-2031)
2.2 Global DNA Medicine Based on DNA Modification Growth Trends by Region
2.2.1 Global DNA Medicine Based on DNA Modification Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 DNA Medicine Based on DNA Modification Historic Market Size by Region (2020-2025)
2.2.3 DNA Medicine Based on DNA Modification Forecasted Market Size by Region (2026-2031)
2.3 DNA Medicine Based on DNA Modification Market Dynamics
2.3.1 DNA Medicine Based on DNA Modification Industry Trends
2.3.2 DNA Medicine Based on DNA Modification Market Drivers
2.3.3 DNA Medicine Based on DNA Modification Market Challenges
2.3.4 DNA Medicine Based on DNA Modification Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top DNA Medicine Based on DNA Modification Players by Revenue
3.1.1 Global Top DNA Medicine Based on DNA Modification Players by Revenue (2020-2025)
3.1.2 Global DNA Medicine Based on DNA Modification Revenue Market Share by Players (2020-2025)
3.2 Global DNA Medicine Based on DNA Modification Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by DNA Medicine Based on DNA Modification Revenue
3.4 Global DNA Medicine Based on DNA Modification Market Concentration Ratio
3.4.1 Global DNA Medicine Based on DNA Modification Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by DNA Medicine Based on DNA Modification Revenue in 2024
3.5 Global Key Players of DNA Medicine Based on DNA Modification Head office and Area Served
3.6 Global Key Players of DNA Medicine Based on DNA Modification, Product and Application
3.7 Global Key Players of DNA Medicine Based on DNA Modification, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 DNA Medicine Based on DNA Modification Breakdown Data by Type
4.1 Global DNA Medicine Based on DNA Modification Historic Market Size by Type (2020-2025)
4.2 Global DNA Medicine Based on DNA Modification Forecasted Market Size by Type (2026-2031)
5 DNA Medicine Based on DNA Modification Breakdown Data by Application
5.1 Global DNA Medicine Based on DNA Modification Historic Market Size by Application (2020-2025)
5.2 Global DNA Medicine Based on DNA Modification Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America DNA Medicine Based on DNA Modification Market Size (2020-2031)
6.2 North America DNA Medicine Based on DNA Modification Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America DNA Medicine Based on DNA Modification Market Size by Country (2020-2025)
6.4 North America DNA Medicine Based on DNA Modification Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe DNA Medicine Based on DNA Modification Market Size (2020-2031)
7.2 Europe DNA Medicine Based on DNA Modification Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe DNA Medicine Based on DNA Modification Market Size by Country (2020-2025)
7.4 Europe DNA Medicine Based on DNA Modification Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific DNA Medicine Based on DNA Modification Market Size (2020-2031)
8.2 Asia-Pacific DNA Medicine Based on DNA Modification Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific DNA Medicine Based on DNA Modification Market Size by Region (2020-2025)
8.4 Asia-Pacific DNA Medicine Based on DNA Modification Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America DNA Medicine Based on DNA Modification Market Size (2020-2031)
9.2 Latin America DNA Medicine Based on DNA Modification Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America DNA Medicine Based on DNA Modification Market Size by Country (2020-2025)
9.4 Latin America DNA Medicine Based on DNA Modification Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa DNA Medicine Based on DNA Modification Market Size (2020-2031)
10.2 Middle East & Africa DNA Medicine Based on DNA Modification Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa DNA Medicine Based on DNA Modification Market Size by Country (2020-2025)
10.4 Middle East & Africa DNA Medicine Based on DNA Modification Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biogen
11.1.1 Biogen Company Details
11.1.2 Biogen Business Overview
11.1.3 Biogen DNA Medicine Based on DNA Modification Introduction
11.1.4 Biogen Revenue in DNA Medicine Based on DNA Modification Business (2020-2025)
11.1.5 Biogen Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis DNA Medicine Based on DNA Modification Introduction
11.2.4 Novartis Revenue in DNA Medicine Based on DNA Modification Business (2020-2025)
11.2.5 Novartis Recent Development
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Details
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences DNA Medicine Based on DNA Modification Introduction
11.3.4 Gilead Sciences Revenue in DNA Medicine Based on DNA Modification Business (2020-2025)
11.3.5 Gilead Sciences Recent Development
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Details
11.4.2 Sarepta Therapeutics Business Overview
11.4.3 Sarepta Therapeutics DNA Medicine Based on DNA Modification Introduction
11.4.4 Sarepta Therapeutics Revenue in DNA Medicine Based on DNA Modification Business (2020-2025)
11.4.5 Sarepta Therapeutics Recent Development
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Details
11.5.2 Alnylam Pharmaceuticals Business Overview
11.5.3 Alnylam Pharmaceuticals DNA Medicine Based on DNA Modification Introduction
11.5.4 Alnylam Pharmaceuticals Revenue in DNA Medicine Based on DNA Modification Business (2020-2025)
11.5.5 Alnylam Pharmaceuticals Recent Development
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen DNA Medicine Based on DNA Modification Introduction
11.6.4 Amgen Revenue in DNA Medicine Based on DNA Modification Business (2020-2025)
11.6.5 Amgen Recent Development
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Details
11.7.2 Spark Therapeutics Business Overview
11.7.3 Spark Therapeutics DNA Medicine Based on DNA Modification Introduction
11.7.4 Spark Therapeutics Revenue in DNA Medicine Based on DNA Modification Business (2020-2025)
11.7.5 Spark Therapeutics Recent Development
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Details
11.8.2 Akcea Therapeutics Business Overview
11.8.3 Akcea Therapeutics DNA Medicine Based on DNA Modification Introduction
11.8.4 Akcea Therapeutics Revenue in DNA Medicine Based on DNA Modification Business (2020-2025)
11.8.5 Akcea Therapeutics Recent Development
11.9 Sunway Biotech
11.9.1 Sunway Biotech Company Details
11.9.2 Sunway Biotech Business Overview
11.9.3 Sunway Biotech DNA Medicine Based on DNA Modification Introduction
11.9.4 Sunway Biotech Revenue in DNA Medicine Based on DNA Modification Business (2020-2025)
11.9.5 Sunway Biotech Recent Development
11.10 SIBIONO
11.10.1 SIBIONO Company Details
11.10.2 SIBIONO Business Overview
11.10.3 SIBIONO DNA Medicine Based on DNA Modification Introduction
11.10.4 SIBIONO Revenue in DNA Medicine Based on DNA Modification Business (2020-2025)
11.10.5 SIBIONO Recent Development
11.11 AnGes
11.11.1 AnGes Company Details
11.11.2 AnGes Business Overview
11.11.3 AnGes DNA Medicine Based on DNA Modification Introduction
11.11.4 AnGes Revenue in DNA Medicine Based on DNA Modification Business (2020-2025)
11.11.5 AnGes Recent Development
11.12 Orchard Therapeutics
11.12.1 Orchard Therapeutics Company Details
11.12.2 Orchard Therapeutics Business Overview
11.12.3 Orchard Therapeutics DNA Medicine Based on DNA Modification Introduction
11.12.4 Orchard Therapeutics Revenue in DNA Medicine Based on DNA Modification Business (2020-2025)
11.12.5 Orchard Therapeutics Recent Development
11.13 Human Stem Cells Institute
11.13.1 Human Stem Cells Institute Company Details
11.13.2 Human Stem Cells Institute Business Overview
11.13.3 Human Stem Cells Institute DNA Medicine Based on DNA Modification Introduction
11.13.4 Human Stem Cells Institute Revenue in DNA Medicine Based on DNA Modification Business (2020-2025)
11.13.5 Human Stem Cells Institute Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global DNA Medicine Based on DNA Modification Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Viral
1.2.3 Non-viral
1.3 Market by Application
1.3.1 Global DNA Medicine Based on DNA Modification Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global DNA Medicine Based on DNA Modification Market Perspective (2020-2031)
2.2 Global DNA Medicine Based on DNA Modification Growth Trends by Region
2.2.1 Global DNA Medicine Based on DNA Modification Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 DNA Medicine Based on DNA Modification Historic Market Size by Region (2020-2025)
2.2.3 DNA Medicine Based on DNA Modification Forecasted Market Size by Region (2026-2031)
2.3 DNA Medicine Based on DNA Modification Market Dynamics
2.3.1 DNA Medicine Based on DNA Modification Industry Trends
2.3.2 DNA Medicine Based on DNA Modification Market Drivers
2.3.3 DNA Medicine Based on DNA Modification Market Challenges
2.3.4 DNA Medicine Based on DNA Modification Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top DNA Medicine Based on DNA Modification Players by Revenue
3.1.1 Global Top DNA Medicine Based on DNA Modification Players by Revenue (2020-2025)
3.1.2 Global DNA Medicine Based on DNA Modification Revenue Market Share by Players (2020-2025)
3.2 Global DNA Medicine Based on DNA Modification Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by DNA Medicine Based on DNA Modification Revenue
3.4 Global DNA Medicine Based on DNA Modification Market Concentration Ratio
3.4.1 Global DNA Medicine Based on DNA Modification Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by DNA Medicine Based on DNA Modification Revenue in 2024
3.5 Global Key Players of DNA Medicine Based on DNA Modification Head office and Area Served
3.6 Global Key Players of DNA Medicine Based on DNA Modification, Product and Application
3.7 Global Key Players of DNA Medicine Based on DNA Modification, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 DNA Medicine Based on DNA Modification Breakdown Data by Type
4.1 Global DNA Medicine Based on DNA Modification Historic Market Size by Type (2020-2025)
4.2 Global DNA Medicine Based on DNA Modification Forecasted Market Size by Type (2026-2031)
5 DNA Medicine Based on DNA Modification Breakdown Data by Application
5.1 Global DNA Medicine Based on DNA Modification Historic Market Size by Application (2020-2025)
5.2 Global DNA Medicine Based on DNA Modification Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America DNA Medicine Based on DNA Modification Market Size (2020-2031)
6.2 North America DNA Medicine Based on DNA Modification Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America DNA Medicine Based on DNA Modification Market Size by Country (2020-2025)
6.4 North America DNA Medicine Based on DNA Modification Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe DNA Medicine Based on DNA Modification Market Size (2020-2031)
7.2 Europe DNA Medicine Based on DNA Modification Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe DNA Medicine Based on DNA Modification Market Size by Country (2020-2025)
7.4 Europe DNA Medicine Based on DNA Modification Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific DNA Medicine Based on DNA Modification Market Size (2020-2031)
8.2 Asia-Pacific DNA Medicine Based on DNA Modification Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific DNA Medicine Based on DNA Modification Market Size by Region (2020-2025)
8.4 Asia-Pacific DNA Medicine Based on DNA Modification Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America DNA Medicine Based on DNA Modification Market Size (2020-2031)
9.2 Latin America DNA Medicine Based on DNA Modification Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America DNA Medicine Based on DNA Modification Market Size by Country (2020-2025)
9.4 Latin America DNA Medicine Based on DNA Modification Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa DNA Medicine Based on DNA Modification Market Size (2020-2031)
10.2 Middle East & Africa DNA Medicine Based on DNA Modification Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa DNA Medicine Based on DNA Modification Market Size by Country (2020-2025)
10.4 Middle East & Africa DNA Medicine Based on DNA Modification Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biogen
11.1.1 Biogen Company Details
11.1.2 Biogen Business Overview
11.1.3 Biogen DNA Medicine Based on DNA Modification Introduction
11.1.4 Biogen Revenue in DNA Medicine Based on DNA Modification Business (2020-2025)
11.1.5 Biogen Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis DNA Medicine Based on DNA Modification Introduction
11.2.4 Novartis Revenue in DNA Medicine Based on DNA Modification Business (2020-2025)
11.2.5 Novartis Recent Development
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Details
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences DNA Medicine Based on DNA Modification Introduction
11.3.4 Gilead Sciences Revenue in DNA Medicine Based on DNA Modification Business (2020-2025)
11.3.5 Gilead Sciences Recent Development
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Details
11.4.2 Sarepta Therapeutics Business Overview
11.4.3 Sarepta Therapeutics DNA Medicine Based on DNA Modification Introduction
11.4.4 Sarepta Therapeutics Revenue in DNA Medicine Based on DNA Modification Business (2020-2025)
11.4.5 Sarepta Therapeutics Recent Development
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Details
11.5.2 Alnylam Pharmaceuticals Business Overview
11.5.3 Alnylam Pharmaceuticals DNA Medicine Based on DNA Modification Introduction
11.5.4 Alnylam Pharmaceuticals Revenue in DNA Medicine Based on DNA Modification Business (2020-2025)
11.5.5 Alnylam Pharmaceuticals Recent Development
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen DNA Medicine Based on DNA Modification Introduction
11.6.4 Amgen Revenue in DNA Medicine Based on DNA Modification Business (2020-2025)
11.6.5 Amgen Recent Development
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Details
11.7.2 Spark Therapeutics Business Overview
11.7.3 Spark Therapeutics DNA Medicine Based on DNA Modification Introduction
11.7.4 Spark Therapeutics Revenue in DNA Medicine Based on DNA Modification Business (2020-2025)
11.7.5 Spark Therapeutics Recent Development
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Details
11.8.2 Akcea Therapeutics Business Overview
11.8.3 Akcea Therapeutics DNA Medicine Based on DNA Modification Introduction
11.8.4 Akcea Therapeutics Revenue in DNA Medicine Based on DNA Modification Business (2020-2025)
11.8.5 Akcea Therapeutics Recent Development
11.9 Sunway Biotech
11.9.1 Sunway Biotech Company Details
11.9.2 Sunway Biotech Business Overview
11.9.3 Sunway Biotech DNA Medicine Based on DNA Modification Introduction
11.9.4 Sunway Biotech Revenue in DNA Medicine Based on DNA Modification Business (2020-2025)
11.9.5 Sunway Biotech Recent Development
11.10 SIBIONO
11.10.1 SIBIONO Company Details
11.10.2 SIBIONO Business Overview
11.10.3 SIBIONO DNA Medicine Based on DNA Modification Introduction
11.10.4 SIBIONO Revenue in DNA Medicine Based on DNA Modification Business (2020-2025)
11.10.5 SIBIONO Recent Development
11.11 AnGes
11.11.1 AnGes Company Details
11.11.2 AnGes Business Overview
11.11.3 AnGes DNA Medicine Based on DNA Modification Introduction
11.11.4 AnGes Revenue in DNA Medicine Based on DNA Modification Business (2020-2025)
11.11.5 AnGes Recent Development
11.12 Orchard Therapeutics
11.12.1 Orchard Therapeutics Company Details
11.12.2 Orchard Therapeutics Business Overview
11.12.3 Orchard Therapeutics DNA Medicine Based on DNA Modification Introduction
11.12.4 Orchard Therapeutics Revenue in DNA Medicine Based on DNA Modification Business (2020-2025)
11.12.5 Orchard Therapeutics Recent Development
11.13 Human Stem Cells Institute
11.13.1 Human Stem Cells Institute Company Details
11.13.2 Human Stem Cells Institute Business Overview
11.13.3 Human Stem Cells Institute DNA Medicine Based on DNA Modification Introduction
11.13.4 Human Stem Cells Institute Revenue in DNA Medicine Based on DNA Modification Business (2020-2025)
11.13.5 Human Stem Cells Institute Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global DNA Medicine Based on DNA Modification Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Viral
Table 3. Key Players of Non-viral
Table 4. Global DNA Medicine Based on DNA Modification Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global DNA Medicine Based on DNA Modification Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global DNA Medicine Based on DNA Modification Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global DNA Medicine Based on DNA Modification Market Share by Region (2020-2025)
Table 8. Global DNA Medicine Based on DNA Modification Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global DNA Medicine Based on DNA Modification Market Share by Region (2026-2031)
Table 10. DNA Medicine Based on DNA Modification Market Trends
Table 11. DNA Medicine Based on DNA Modification Market Drivers
Table 12. DNA Medicine Based on DNA Modification Market Challenges
Table 13. DNA Medicine Based on DNA Modification Market Restraints
Table 14. Global DNA Medicine Based on DNA Modification Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global DNA Medicine Based on DNA Modification Market Share by Players (2020-2025)
Table 16. Global Top DNA Medicine Based on DNA Modification Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA Medicine Based on DNA Modification as of 2024)
Table 17. Ranking of Global Top DNA Medicine Based on DNA Modification Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by DNA Medicine Based on DNA Modification Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of DNA Medicine Based on DNA Modification, Headquarters and Area Served
Table 20. Global Key Players of DNA Medicine Based on DNA Modification, Product and Application
Table 21. Global Key Players of DNA Medicine Based on DNA Modification, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global DNA Medicine Based on DNA Modification Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global DNA Medicine Based on DNA Modification Revenue Market Share by Type (2020-2025)
Table 25. Global DNA Medicine Based on DNA Modification Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global DNA Medicine Based on DNA Modification Revenue Market Share by Type (2026-2031)
Table 27. Global DNA Medicine Based on DNA Modification Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global DNA Medicine Based on DNA Modification Revenue Market Share by Application (2020-2025)
Table 29. Global DNA Medicine Based on DNA Modification Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global DNA Medicine Based on DNA Modification Revenue Market Share by Application (2026-2031)
Table 31. North America DNA Medicine Based on DNA Modification Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America DNA Medicine Based on DNA Modification Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America DNA Medicine Based on DNA Modification Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe DNA Medicine Based on DNA Modification Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe DNA Medicine Based on DNA Modification Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe DNA Medicine Based on DNA Modification Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific DNA Medicine Based on DNA Modification Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific DNA Medicine Based on DNA Modification Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific DNA Medicine Based on DNA Modification Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America DNA Medicine Based on DNA Modification Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America DNA Medicine Based on DNA Modification Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America DNA Medicine Based on DNA Modification Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa DNA Medicine Based on DNA Modification Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa DNA Medicine Based on DNA Modification Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa DNA Medicine Based on DNA Modification Market Size by Country (2026-2031) & (US$ Million)
Table 46. Biogen Company Details
Table 47. Biogen Business Overview
Table 48. Biogen DNA Medicine Based on DNA Modification Product
Table 49. Biogen Revenue in DNA Medicine Based on DNA Modification Business (2020-2025) & (US$ Million)
Table 50. Biogen Recent Development
Table 51. Novartis Company Details
Table 52. Novartis Business Overview
Table 53. Novartis DNA Medicine Based on DNA Modification Product
Table 54. Novartis Revenue in DNA Medicine Based on DNA Modification Business (2020-2025) & (US$ Million)
Table 55. Novartis Recent Development
Table 56. Gilead Sciences Company Details
Table 57. Gilead Sciences Business Overview
Table 58. Gilead Sciences DNA Medicine Based on DNA Modification Product
Table 59. Gilead Sciences Revenue in DNA Medicine Based on DNA Modification Business (2020-2025) & (US$ Million)
Table 60. Gilead Sciences Recent Development
Table 61. Sarepta Therapeutics Company Details
Table 62. Sarepta Therapeutics Business Overview
Table 63. Sarepta Therapeutics DNA Medicine Based on DNA Modification Product
Table 64. Sarepta Therapeutics Revenue in DNA Medicine Based on DNA Modification Business (2020-2025) & (US$ Million)
Table 65. Sarepta Therapeutics Recent Development
Table 66. Alnylam Pharmaceuticals Company Details
Table 67. Alnylam Pharmaceuticals Business Overview
Table 68. Alnylam Pharmaceuticals DNA Medicine Based on DNA Modification Product
Table 69. Alnylam Pharmaceuticals Revenue in DNA Medicine Based on DNA Modification Business (2020-2025) & (US$ Million)
Table 70. Alnylam Pharmaceuticals Recent Development
Table 71. Amgen Company Details
Table 72. Amgen Business Overview
Table 73. Amgen DNA Medicine Based on DNA Modification Product
Table 74. Amgen Revenue in DNA Medicine Based on DNA Modification Business (2020-2025) & (US$ Million)
Table 75. Amgen Recent Development
Table 76. Spark Therapeutics Company Details
Table 77. Spark Therapeutics Business Overview
Table 78. Spark Therapeutics DNA Medicine Based on DNA Modification Product
Table 79. Spark Therapeutics Revenue in DNA Medicine Based on DNA Modification Business (2020-2025) & (US$ Million)
Table 80. Spark Therapeutics Recent Development
Table 81. Akcea Therapeutics Company Details
Table 82. Akcea Therapeutics Business Overview
Table 83. Akcea Therapeutics DNA Medicine Based on DNA Modification Product
Table 84. Akcea Therapeutics Revenue in DNA Medicine Based on DNA Modification Business (2020-2025) & (US$ Million)
Table 85. Akcea Therapeutics Recent Development
Table 86. Sunway Biotech Company Details
Table 87. Sunway Biotech Business Overview
Table 88. Sunway Biotech DNA Medicine Based on DNA Modification Product
Table 89. Sunway Biotech Revenue in DNA Medicine Based on DNA Modification Business (2020-2025) & (US$ Million)
Table 90. Sunway Biotech Recent Development
Table 91. SIBIONO Company Details
Table 92. SIBIONO Business Overview
Table 93. SIBIONO DNA Medicine Based on DNA Modification Product
Table 94. SIBIONO Revenue in DNA Medicine Based on DNA Modification Business (2020-2025) & (US$ Million)
Table 95. SIBIONO Recent Development
Table 96. AnGes Company Details
Table 97. AnGes Business Overview
Table 98. AnGes DNA Medicine Based on DNA Modification Product
Table 99. AnGes Revenue in DNA Medicine Based on DNA Modification Business (2020-2025) & (US$ Million)
Table 100. AnGes Recent Development
Table 101. Orchard Therapeutics Company Details
Table 102. Orchard Therapeutics Business Overview
Table 103. Orchard Therapeutics DNA Medicine Based on DNA Modification Product
Table 104. Orchard Therapeutics Revenue in DNA Medicine Based on DNA Modification Business (2020-2025) & (US$ Million)
Table 105. Orchard Therapeutics Recent Development
Table 106. Human Stem Cells Institute Company Details
Table 107. Human Stem Cells Institute Business Overview
Table 108. Human Stem Cells Institute DNA Medicine Based on DNA Modification Product
Table 109. Human Stem Cells Institute Revenue in DNA Medicine Based on DNA Modification Business (2020-2025) & (US$ Million)
Table 110. Human Stem Cells Institute Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
Table 114. Authors List of This Report
List of Figures
Figure 1. DNA Medicine Based on DNA Modification Picture
Figure 2. Global DNA Medicine Based on DNA Modification Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global DNA Medicine Based on DNA Modification Market Share by Type: 2024 VS 2031
Figure 4. Viral Features
Figure 5. Non-viral Features
Figure 6. Global DNA Medicine Based on DNA Modification Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global DNA Medicine Based on DNA Modification Market Share by Application: 2024 VS 2031
Figure 8. Neurological Diseases Case Studies
Figure 9. Cancer Case Studies
Figure 10. Other Case Studies
Figure 11. DNA Medicine Based on DNA Modification Report Years Considered
Figure 12. Global DNA Medicine Based on DNA Modification Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global DNA Medicine Based on DNA Modification Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global DNA Medicine Based on DNA Modification Market Share by Region: 2024 VS 2031
Figure 15. Global DNA Medicine Based on DNA Modification Market Share by Players in 2024
Figure 16. Global Top DNA Medicine Based on DNA Modification Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA Medicine Based on DNA Modification as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by DNA Medicine Based on DNA Modification Revenue in 2024
Figure 18. North America DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America DNA Medicine Based on DNA Modification Market Share by Country (2020-2031)
Figure 20. United States DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe DNA Medicine Based on DNA Modification Market Share by Country (2020-2031)
Figure 24. Germany DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific DNA Medicine Based on DNA Modification Market Share by Region (2020-2031)
Figure 32. China DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America DNA Medicine Based on DNA Modification Market Share by Country (2020-2031)
Figure 40. Mexico DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa DNA Medicine Based on DNA Modification Market Share by Country (2020-2031)
Figure 44. Turkey DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Biogen Revenue Growth Rate in DNA Medicine Based on DNA Modification Business (2020-2025)
Figure 48. Novartis Revenue Growth Rate in DNA Medicine Based on DNA Modification Business (2020-2025)
Figure 49. Gilead Sciences Revenue Growth Rate in DNA Medicine Based on DNA Modification Business (2020-2025)
Figure 50. Sarepta Therapeutics Revenue Growth Rate in DNA Medicine Based on DNA Modification Business (2020-2025)
Figure 51. Alnylam Pharmaceuticals Revenue Growth Rate in DNA Medicine Based on DNA Modification Business (2020-2025)
Figure 52. Amgen Revenue Growth Rate in DNA Medicine Based on DNA Modification Business (2020-2025)
Figure 53. Spark Therapeutics Revenue Growth Rate in DNA Medicine Based on DNA Modification Business (2020-2025)
Figure 54. Akcea Therapeutics Revenue Growth Rate in DNA Medicine Based on DNA Modification Business (2020-2025)
Figure 55. Sunway Biotech Revenue Growth Rate in DNA Medicine Based on DNA Modification Business (2020-2025)
Figure 56. SIBIONO Revenue Growth Rate in DNA Medicine Based on DNA Modification Business (2020-2025)
Figure 57. AnGes Revenue Growth Rate in DNA Medicine Based on DNA Modification Business (2020-2025)
Figure 58. Orchard Therapeutics Revenue Growth Rate in DNA Medicine Based on DNA Modification Business (2020-2025)
Figure 59. Human Stem Cells Institute Revenue Growth Rate in DNA Medicine Based on DNA Modification Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global DNA Medicine Based on DNA Modification Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Viral
Table 3. Key Players of Non-viral
Table 4. Global DNA Medicine Based on DNA Modification Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global DNA Medicine Based on DNA Modification Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global DNA Medicine Based on DNA Modification Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global DNA Medicine Based on DNA Modification Market Share by Region (2020-2025)
Table 8. Global DNA Medicine Based on DNA Modification Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global DNA Medicine Based on DNA Modification Market Share by Region (2026-2031)
Table 10. DNA Medicine Based on DNA Modification Market Trends
Table 11. DNA Medicine Based on DNA Modification Market Drivers
Table 12. DNA Medicine Based on DNA Modification Market Challenges
Table 13. DNA Medicine Based on DNA Modification Market Restraints
Table 14. Global DNA Medicine Based on DNA Modification Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global DNA Medicine Based on DNA Modification Market Share by Players (2020-2025)
Table 16. Global Top DNA Medicine Based on DNA Modification Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA Medicine Based on DNA Modification as of 2024)
Table 17. Ranking of Global Top DNA Medicine Based on DNA Modification Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by DNA Medicine Based on DNA Modification Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of DNA Medicine Based on DNA Modification, Headquarters and Area Served
Table 20. Global Key Players of DNA Medicine Based on DNA Modification, Product and Application
Table 21. Global Key Players of DNA Medicine Based on DNA Modification, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global DNA Medicine Based on DNA Modification Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global DNA Medicine Based on DNA Modification Revenue Market Share by Type (2020-2025)
Table 25. Global DNA Medicine Based on DNA Modification Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global DNA Medicine Based on DNA Modification Revenue Market Share by Type (2026-2031)
Table 27. Global DNA Medicine Based on DNA Modification Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global DNA Medicine Based on DNA Modification Revenue Market Share by Application (2020-2025)
Table 29. Global DNA Medicine Based on DNA Modification Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global DNA Medicine Based on DNA Modification Revenue Market Share by Application (2026-2031)
Table 31. North America DNA Medicine Based on DNA Modification Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America DNA Medicine Based on DNA Modification Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America DNA Medicine Based on DNA Modification Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe DNA Medicine Based on DNA Modification Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe DNA Medicine Based on DNA Modification Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe DNA Medicine Based on DNA Modification Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific DNA Medicine Based on DNA Modification Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific DNA Medicine Based on DNA Modification Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific DNA Medicine Based on DNA Modification Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America DNA Medicine Based on DNA Modification Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America DNA Medicine Based on DNA Modification Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America DNA Medicine Based on DNA Modification Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa DNA Medicine Based on DNA Modification Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa DNA Medicine Based on DNA Modification Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa DNA Medicine Based on DNA Modification Market Size by Country (2026-2031) & (US$ Million)
Table 46. Biogen Company Details
Table 47. Biogen Business Overview
Table 48. Biogen DNA Medicine Based on DNA Modification Product
Table 49. Biogen Revenue in DNA Medicine Based on DNA Modification Business (2020-2025) & (US$ Million)
Table 50. Biogen Recent Development
Table 51. Novartis Company Details
Table 52. Novartis Business Overview
Table 53. Novartis DNA Medicine Based on DNA Modification Product
Table 54. Novartis Revenue in DNA Medicine Based on DNA Modification Business (2020-2025) & (US$ Million)
Table 55. Novartis Recent Development
Table 56. Gilead Sciences Company Details
Table 57. Gilead Sciences Business Overview
Table 58. Gilead Sciences DNA Medicine Based on DNA Modification Product
Table 59. Gilead Sciences Revenue in DNA Medicine Based on DNA Modification Business (2020-2025) & (US$ Million)
Table 60. Gilead Sciences Recent Development
Table 61. Sarepta Therapeutics Company Details
Table 62. Sarepta Therapeutics Business Overview
Table 63. Sarepta Therapeutics DNA Medicine Based on DNA Modification Product
Table 64. Sarepta Therapeutics Revenue in DNA Medicine Based on DNA Modification Business (2020-2025) & (US$ Million)
Table 65. Sarepta Therapeutics Recent Development
Table 66. Alnylam Pharmaceuticals Company Details
Table 67. Alnylam Pharmaceuticals Business Overview
Table 68. Alnylam Pharmaceuticals DNA Medicine Based on DNA Modification Product
Table 69. Alnylam Pharmaceuticals Revenue in DNA Medicine Based on DNA Modification Business (2020-2025) & (US$ Million)
Table 70. Alnylam Pharmaceuticals Recent Development
Table 71. Amgen Company Details
Table 72. Amgen Business Overview
Table 73. Amgen DNA Medicine Based on DNA Modification Product
Table 74. Amgen Revenue in DNA Medicine Based on DNA Modification Business (2020-2025) & (US$ Million)
Table 75. Amgen Recent Development
Table 76. Spark Therapeutics Company Details
Table 77. Spark Therapeutics Business Overview
Table 78. Spark Therapeutics DNA Medicine Based on DNA Modification Product
Table 79. Spark Therapeutics Revenue in DNA Medicine Based on DNA Modification Business (2020-2025) & (US$ Million)
Table 80. Spark Therapeutics Recent Development
Table 81. Akcea Therapeutics Company Details
Table 82. Akcea Therapeutics Business Overview
Table 83. Akcea Therapeutics DNA Medicine Based on DNA Modification Product
Table 84. Akcea Therapeutics Revenue in DNA Medicine Based on DNA Modification Business (2020-2025) & (US$ Million)
Table 85. Akcea Therapeutics Recent Development
Table 86. Sunway Biotech Company Details
Table 87. Sunway Biotech Business Overview
Table 88. Sunway Biotech DNA Medicine Based on DNA Modification Product
Table 89. Sunway Biotech Revenue in DNA Medicine Based on DNA Modification Business (2020-2025) & (US$ Million)
Table 90. Sunway Biotech Recent Development
Table 91. SIBIONO Company Details
Table 92. SIBIONO Business Overview
Table 93. SIBIONO DNA Medicine Based on DNA Modification Product
Table 94. SIBIONO Revenue in DNA Medicine Based on DNA Modification Business (2020-2025) & (US$ Million)
Table 95. SIBIONO Recent Development
Table 96. AnGes Company Details
Table 97. AnGes Business Overview
Table 98. AnGes DNA Medicine Based on DNA Modification Product
Table 99. AnGes Revenue in DNA Medicine Based on DNA Modification Business (2020-2025) & (US$ Million)
Table 100. AnGes Recent Development
Table 101. Orchard Therapeutics Company Details
Table 102. Orchard Therapeutics Business Overview
Table 103. Orchard Therapeutics DNA Medicine Based on DNA Modification Product
Table 104. Orchard Therapeutics Revenue in DNA Medicine Based on DNA Modification Business (2020-2025) & (US$ Million)
Table 105. Orchard Therapeutics Recent Development
Table 106. Human Stem Cells Institute Company Details
Table 107. Human Stem Cells Institute Business Overview
Table 108. Human Stem Cells Institute DNA Medicine Based on DNA Modification Product
Table 109. Human Stem Cells Institute Revenue in DNA Medicine Based on DNA Modification Business (2020-2025) & (US$ Million)
Table 110. Human Stem Cells Institute Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
Table 114. Authors List of This Report
List of Figures
Figure 1. DNA Medicine Based on DNA Modification Picture
Figure 2. Global DNA Medicine Based on DNA Modification Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global DNA Medicine Based on DNA Modification Market Share by Type: 2024 VS 2031
Figure 4. Viral Features
Figure 5. Non-viral Features
Figure 6. Global DNA Medicine Based on DNA Modification Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global DNA Medicine Based on DNA Modification Market Share by Application: 2024 VS 2031
Figure 8. Neurological Diseases Case Studies
Figure 9. Cancer Case Studies
Figure 10. Other Case Studies
Figure 11. DNA Medicine Based on DNA Modification Report Years Considered
Figure 12. Global DNA Medicine Based on DNA Modification Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global DNA Medicine Based on DNA Modification Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global DNA Medicine Based on DNA Modification Market Share by Region: 2024 VS 2031
Figure 15. Global DNA Medicine Based on DNA Modification Market Share by Players in 2024
Figure 16. Global Top DNA Medicine Based on DNA Modification Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA Medicine Based on DNA Modification as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by DNA Medicine Based on DNA Modification Revenue in 2024
Figure 18. North America DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America DNA Medicine Based on DNA Modification Market Share by Country (2020-2031)
Figure 20. United States DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe DNA Medicine Based on DNA Modification Market Share by Country (2020-2031)
Figure 24. Germany DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific DNA Medicine Based on DNA Modification Market Share by Region (2020-2031)
Figure 32. China DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America DNA Medicine Based on DNA Modification Market Share by Country (2020-2031)
Figure 40. Mexico DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa DNA Medicine Based on DNA Modification Market Share by Country (2020-2031)
Figure 44. Turkey DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Biogen Revenue Growth Rate in DNA Medicine Based on DNA Modification Business (2020-2025)
Figure 48. Novartis Revenue Growth Rate in DNA Medicine Based on DNA Modification Business (2020-2025)
Figure 49. Gilead Sciences Revenue Growth Rate in DNA Medicine Based on DNA Modification Business (2020-2025)
Figure 50. Sarepta Therapeutics Revenue Growth Rate in DNA Medicine Based on DNA Modification Business (2020-2025)
Figure 51. Alnylam Pharmaceuticals Revenue Growth Rate in DNA Medicine Based on DNA Modification Business (2020-2025)
Figure 52. Amgen Revenue Growth Rate in DNA Medicine Based on DNA Modification Business (2020-2025)
Figure 53. Spark Therapeutics Revenue Growth Rate in DNA Medicine Based on DNA Modification Business (2020-2025)
Figure 54. Akcea Therapeutics Revenue Growth Rate in DNA Medicine Based on DNA Modification Business (2020-2025)
Figure 55. Sunway Biotech Revenue Growth Rate in DNA Medicine Based on DNA Modification Business (2020-2025)
Figure 56. SIBIONO Revenue Growth Rate in DNA Medicine Based on DNA Modification Business (2020-2025)
Figure 57. AnGes Revenue Growth Rate in DNA Medicine Based on DNA Modification Business (2020-2025)
Figure 58. Orchard Therapeutics Revenue Growth Rate in DNA Medicine Based on DNA Modification Business (2020-2025)
Figure 59. Human Stem Cells Institute Revenue Growth Rate in DNA Medicine Based on DNA Modification Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Electrolytes for Lithium-Ion Batteries Market Research Report 2025
Jul 14, 25
Global Vanadium Products Market Research Report 2025
Jul 14, 25
Global High-purity Vanadium Oxide Market Research Report 2025
Jul 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232